These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13568225)

  • 1. [Use of sulfonylureas in therapy of diabetes mellitus].
    VAISSMAN I; ALVES AC
    Rev Bras Med; 1958 Feb; 15(2):84-6. PubMed ID: 13568225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypoglycemic sulfonylureas in the treatment of diabetes mellitus].
    ARDUINO F
    Hospital (Rio J); 1959 Jan; 55(1):1-11. PubMed ID: 13640519
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B
    Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of sulfonylureas in treatment of diabetes mellitus].
    HOFSTETTER JR; RAMEL C
    Schweiz Med Wochenschr; 1958 Aug; 88(34):821-7. PubMed ID: 13580207
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfonylureas in diabetes mellitus.
    SOBEL GW; LEVINE R
    J Am Diet Assoc; 1958 Oct; 34(10):1072-4. PubMed ID: 13587149
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of the oral sulfonylureas in diabetes mellitus.
    EASLEY AS
    J Tn State Med Assoc; 1958 Oct; 51(10):417-22. PubMed ID: 13588696
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of the sulfonylureas in diabetes mellitus.
    SUGAR SJ
    Ann N Y Acad Sci; 1957 Jul; 71(1):256-63. PubMed ID: 13459222
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on evaluation of a test method for indication of treatment of diabetes mellitus with sulfonylureas].
    HALLER H; STRAUZENBERG SE
    Dtsch Gesundheitsw; 1958 Dec; 13(52):1715-9. PubMed ID: 13630089
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
    Al-Ozairi E; Sibal L; Home P
    Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R; Erdmann E
    Herz; 2008 Apr; 33(3):178-83. PubMed ID: 18568311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical inquiries. What is the best medical therapy for new-onset type 2 diabetes?
    Klam C; Neher JO; Mayo H; Lo V
    J Fam Pract; 2006 Nov; 55(11):998-1000. PubMed ID: 17090363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistical results on therapy of diabetes mellitus by synthetic hypoglycemic agents].
    UHRY P; MARCEL G; DUIZEND M; VARIN R; COHEN M; TEXIER
    Bull Mem Soc Med Hop Paris; 1957 Jun 14-21; 73(20-21):630-8. PubMed ID: 13460707
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glimepiride in daily practice].
    Jasik M
    Przegl Lek; 2003; 60(6):409-12. PubMed ID: 14974179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further experience with the use of sulfonylureas in diabetes.
    BEASER SB
    Ann N Y Acad Sci; 1957 Jul; 71(1):264-7. PubMed ID: 13459223
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research on the mechanism of action of sulfonylureas in human diabetes].
    PLATTNER HC; SCHERER J
    Rev Fr Etud Clin Biol; 1957 Oct; 2(8):803-7. PubMed ID: 13494961
    [No Abstract]   [Full Text] [Related]  

  • 20. Modern therapy in diabetes mellitus, insulin, and the oral hypoglycemic agents.
    KIRTLEY WR; PECK FB
    Minn Med; 1958 Sep; 41(9):607-13. PubMed ID: 13577645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.